These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10979947)

  • 1. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.
    Marr KA; Seidel K; Slavin MA; Bowden RA; Schoch HG; Flowers ME; Corey L; Boeckh M
    Blood; 2000 Sep; 96(6):2055-61. PubMed ID: 10979947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole.
    Oliveira JS; Kerbauy FR; Colombo AL; Bahia DM; Pinheiro GS; Silva MR; Ribeiro MS; Raineri G; Kerbauy J
    Braz J Med Biol Res; 2002 Jul; 35(7):789-98. PubMed ID: 12131918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
    Goodman JL; Winston DJ; Greenfield RA; Chandrasekar PH; Fox B; Kaizer H; Shadduck RK; Shea TC; Stiff P; Friedman DJ
    N Engl J Med; 1992 Mar; 326(13):845-51. PubMed ID: 1542320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
    Slavin MA; Osborne B; Adams R; Levenstein MJ; Schoch HG; Feldman AR; Meyers JD; Bowden RA
    J Infect Dis; 1995 Jun; 171(6):1545-52. PubMed ID: 7769290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
    Sarina B; Mariotti J; Bramanti S; Morabito L; Crocchiolo R; Rimondo A; Tordato F; Pocaterra D; Casari E; De Philippis C; Carlo-Stella C; Santoro A; Castagna L
    Transpl Infect Dis; 2018 Aug; 20(4):e12906. PubMed ID: 29668124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.
    Schuster MG; Edwards JE; Sobel JD; Darouiche RO; Karchmer AW; Hadley S; Slotman G; Panzer H; Biswas P; Rex JH
    Ann Intern Med; 2008 Jul; 149(2):83-90. PubMed ID: 18626047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.
    Winston DJ; Pakrasi A; Busuttil RW
    Ann Intern Med; 1999 Nov; 131(10):729-37. PubMed ID: 10577295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
    van Burik JH; Leisenring W; Myerson D; Hackman RC; Shulman HM; Sale GE; Bowden RA; McDonald GB
    Medicine (Baltimore); 1998 Jul; 77(4):246-54. PubMed ID: 9715729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
    Healy CM; Campbell JR; Zaccaria E; Baker CJ
    Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy.
    MacMillan ML; Goodman JL; DeFor TE; Weisdorf DJ
    Am J Med; 2002 Apr; 112(5):369-79. PubMed ID: 11904111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients.
    Pelz RK; Hendrix CW; Swoboda SM; Diener-West M; Merz WG; Hammond J; Lipsett PA
    Ann Surg; 2001 Apr; 233(4):542-8. PubMed ID: 11303137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.
    Ochs L; Shu XO; Miller J; Enright H; Wagner J; Filipovich A; Miller W; Weisdorf D
    Blood; 1995 Nov; 86(10):3979-86. PubMed ID: 7579369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients.
    Hoppe JE; Klausner M; Klingebiel T; Niethammer D
    Mycoses; 1997; 40(1-2):47-54. PubMed ID: 9260481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.